Scinovex
articleTop 1% cited

Huntington's disease: from molecular pathogenesis to clinical treatment

The Lancet Neurology · 2010 · Vol. 10(1) · pp. 83–98
Christopher A. RossSarah J. Tabrizi
Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyNeurological disorders and treatmentsHuntington's diseaseHuntingtinDiseaseNeurodegenerationHuntingtin ProteinNeuroscienceTrinucleotide repeat expansionMedicinePathogenesisBioinformatics

MeSH terms

Huntingtin ProteinAnimalsBrainDisease Models, AnimalHumansHuntington DiseaseMagnetic Resonance ImagingModels, BiologicalNerve Tissue ProteinsNeuronsNuclear ProteinsPeptidesDisease ProgressionHistory, 20th Century

Funding

  • CHDI Foundation
  • Research Councils UK
  • Medical Research Council
Citations
1,697
FWCI
33.15
field-weighted impact
References
163
Percentile
100%
vs. same field & year
Citations per year
Cited by
Advances in therapeutic applications of extracellular vesicles
Science Translational Medicine · 2019 · 983 citations
The development of the concept of ferroptosis
Free Radical Biology and Medicine · 2018 · 1,047 citations
References
Protein aggregation and neurodegenerative disease
Nature Medicine · 2004 · 3,433 citations
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Nature Structural & Molecular Biology · 2008 · 1,407 citations
The functional anatomy of basal ganglia disorders
Trends in Neurosciences · 1989 · 5,321 citations
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Journal of Neurology Neurosurgery & Psychiatry · 2007 · 807 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.